Alan Go
Overview
Explore the profile of Alan Go including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
6520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kula A, Katz R, Zelnick L, Soliman E, Go A, Shlipak M, et al.
Nephrol Dial Transplant
. 2020 Dec;
36(12):2282-2289.
PMID: 33367652
Background: Among patients with chronic kidney disease (CKD), the circulating cardiac biomarkers soluble ST2 (SST2), galectin-3, growth differentiation factor-15 (GDF-15), N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity troponin-T (hsTnT) possibly...
12.
Wang K, Zelnick L, Anderson A, Cohen J, Dobre M, Deo R, et al.
Kidney Int Rep
. 2020 Nov;
5(11):2002-2012.
PMID: 33163721
Introduction: Cardiovascular disease (CVD) is the leading cause of mortality among individuals with chronic kidney disease (CKD). Cardiac biomarkers of myocardial distention, injury, and inflammation may signal unique pathways underlying...
13.
Bansal N, Zelnick L, Go A, Anderson A, Christenson R, Deo R, et al.
J Am Heart Assoc
. 2019 Oct;
8(21):e012336.
PMID: 31645163
Background Cardiac biomarkers may signal mechanistic pathways involved in heart failure (HF), a leading complication in chronic kidney disease. We tested the associations of NT-proBNP (N-terminal pro-B-type natriuretic peptide), high-sensitivity...
14.
Mehta R, Cai X, Hodakowski A, Lee J, Leonard M, Ricardo A, et al.
Clin J Am Soc Nephrol
. 2017 Aug;
12(11):1795-1803.
PMID: 28784656
Background And Objectives: Anemia is an early complication of CKD that is associated with increased morbidity and mortality. Prior data show associations between abnormal mineral metabolism markers and decreased erythropoiesis....
15.
Amdur R, Mukherjee M, Go A, Barrows I, Ramezani A, Shoji J, et al.
PLoS One
. 2016 Feb;
11(2):e0148189.
PMID: 26840403
Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with chronic kidney disease (CKD). In this study, we examined the association between inflammation and AF in 3,762 adults...
16.
Meyer M, Witt D, Delate T, Johnson S, Fang M, Go A, et al.
Thromb Res
. 2015 Oct;
136(6):1160-4.
PMID: 26477821
Background: Thrombophilia testing has limited value in determining the selection and duration of anticoagulation therapy for venous thromboembolism (VTE), yet is commonly performed. This study describes the patterns and appropriateness...
17.
Mehta R, Ying G, Houston S, Isakova T, Nessel L, Ojo A, et al.
Nephrol Dial Transplant
. 2015 Apr;
30(9):1534-41.
PMID: 25910495
Background: Elevated circulating concentrations of phosphate and fibroblast growth factor 23 (FGF23) contribute to the pathogenesis of cardiovascular disease in chronic kidney disease (CKD). Retinopathy is a common manifestation of...
18.
Martindale S, Singh A, Wang H, Steinberg A, Homsi A, Zhang H, et al.
ISRN Oncol
. 2014 Apr;
2014:694591.
PMID: 24693452
Breast cancer survival has significantly improved over the past two decades. However, the diagnosis of breast cancer is lower and the mortality rate remains higher, in African American women (AA)...
19.
Mehta N, Matthews G, Krishnamoorthy P, Shah R, McLaughlin C, Patel P, et al.
Eur Heart J
. 2013 Dec;
35(31):2115-22.
PMID: 24306482
Aims: Genome-wide association studies revealed an association between a locus at 10q11, downstream from CXCL12, and myocardial infarction (MI). However, the relationship among plasma CXCL12, cardiovascular disease (CVD) risk factors,...
20.
Ricardo A, Hacker E, Lora C, Ackerson L, DeSalvo K, Go A, et al.
Ethn Dis
. 2013 Mar;
23(2):202-9.
PMID: 23530302
Objective: Evaluate the reliability and validity of the Kidney Disease Quality of Life Short Form 36 (KDQOL-36) in Hispanics with mild-to-moderate chronic kidney disease (CKD). Design: Cross-sectional Setting: Chronic Renal...